Figure 1From: Protease inhibitor associated mutations compromise the efficacy of therapy in human immunodeficiency virus – 1 (HIV-1) infected pediatric patients: a cross-sectional studyHIV-1 drug resistance mutations correlated with age and duration of ARV therapy (in years).Back to article page